ProQinase GmbH
Industry
- Contract Research Organization-CRO
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on ProQinase GmbH
In Vivo
• By Hazel Dawson
Developing protein kinase inhibitors to treat cancer ProQinase GMBH was established as a wholly owned subsidiary of the Tumor Biology Centre (TBC), Freiburg, in April 2001 to commercialize the cen
In Vivo
Acquisitions Cell Therapeutics to acquire Novuspharma Cell Therapeutics Inc. (Seattle, WA) Novuspharma SPA (Bresso, Italy) Cancer therapeutics companies CTI BioPharma Corp. and Novuspharma SA ha
In Vivo
Acquisitions Hybrigenics buys Semaia in stock swap Hybrigenics SA (Paris, France) Semaia Pharmaceuticals (Dortmund, Germany) Hybrigenics SA (proteomics) has acquired Semaia Pharmaceuticals ,